News
-
Conference Report published
The report of the first EP PerMed conference on personalised medicine research, which took place on 11 and 12 February in Berlin, Germany, is now available.
-
Recordings available: EP PerMed Round Table Spain and Portugal
The second EP PerMed Round Table on 31 March 2025 focused on the adoption of personalised medicine approaches in Spain and Portugal. Recordings of the event are now available.
-
ICPerMed White Paper on Value and Evaluation of Personalised Medicine published
The International Consortium for Personalised Medicine (ICPerMed) has published a new White Paper on “the Value and Evaluation of Personalised Medicine”.
-
EP PerMed launches Innovation Advisory Board
The newly established Innovation Advisory Board is made up of eight esteemed international experts, each providing EP PerMed with invaluable strategic advice and expertise to accelerate innovation in personalised medicine.
EP PerMed JTC 2025
#PGxPM2025
With its second Joint Transnational Call (JTC), EP PerMed aims to fund human health research on pharmacogenomic strategies for personalised medicine approaches. The deadline for submission of pre-proposals was 18 February 2025. Funding decisions are expected to be communicated in October 2025.
EP PerMed Summer School
Mission & Objectives
Governance & Boards
The European Partnership for Personalised Medicine gathers together around 60 partners from 25 countries. The Consortium is managed by a so-called Coordination Unit (CU) and General Assembly (GeA). The day-to-day business, planning and implementation of activities is realized through five Work Packages. The EP PerMed overarching Advisory Bodies are ICPerMed, an Advisory Board and a Stakeholder Forum.